Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
|
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis |
Multiple Sclerosis | Phase4 |
Germany Puerto Rico United Kingdom United States View all
|
NCT06444113 |
|
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE). |
Systemic Lupus Erythematosus, SLE | Phase1 |
China Germany Hungary Netherlands Spain Switzerland View all
|
NCT06335979 |
|
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN |
IC-MPGN | Phase3 |
Argentina Brazil Canada France Germany Greece India Israel Italy Japan Netherlands Poland Slovakia South Korea Spain Switzerland Taiwan Turkey (Türkiye) United Kingdom United States Vietnam View all
|
NCT05755386 |
|
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease |
Steroid-refractory Acute Graft Versus Host Disease | Phase4 | China | NCT06462469 |
|
Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function |
Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase2 |
France Germany Italy Spain United States View all
|
NCT06004661 |
|
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia |
Familial Hypercholesterolemia - Heterozygous | Phase3 |
Argentina Austria Belgium Brazil China Czechia France Germany Greece Hong Kong Hungary Israel Italy Malaysia Netherlands Poland Portugal South Africa Spain Taiwan Turkey (Türkiye) United Kingdom United States View all
|
NCT06597019 |
|
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis |
Atopic Dermatitis | Phase2 |
Argentina Canada China Czechia France Germany Hungary Italy Japan Netherlands Poland Slovakia South Korea Spain Taiwan United Kingdom United States View all
|
NCT06947993 |
|
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) |
Atypical Hemolytic Uremic Syndrome | Phase3 |
China France Germany Italy Japan Spain Turkey (Türkiye) United Kingdom View all
|
NCT05935215 |
|
A 24-week rPMS Study in Real-world Setting for Enerzair |
Asthma | South Korea | NCT05274425 | |
|
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC |
Prostatic Neoplasm | Phase2 |
Brazil Canada China Czechia France Germany Italy Netherlands Poland Singapore South Korea Spain United States View all
|
NCT05849298 |